缺血性卒中专题 |
|
|
|
|
静脉溶栓获益的最大梗死体积阈值与急性缺血性卒中患者发病时间的关系 |
张美霞, 周颖, 张睿婷, 张圣, 楼敏 |
浙江大学医学院附属第二医院神经内科, 浙江 杭州 310009 |
|
Maximal infarct volume to benefit from intravenous thrombolysis and its relation with onset to treatment time |
ZHANG Meixia, ZHOU Ying, ZHANG Ruiting, ZHANG Sheng, LOU Min |
Department of Neurology, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, China |
[1] SAVER J L. Time is brain-quantified[J]. Stroke,2006,37(1):263-266.
[2] LUBY M, WARACH S J, NADAREISHVILI Z, et al. Immediate changes in stroke lesion volumes post thrombolysis predict clinical outcome[J]. Stroke,2014,45(11):3275-3279.
[3] PICANCO M R, CHRISTENSEN S, CAMPBELL B C, et al. Reperfusion after 4.5 hours reduces infarct growth and improves clinical outcomes[J]. Int J Stroke,2014,9(3):266-269.
[4] CHO K H, KWON S U, LEE D H, et al. Early infarct growth predicts long-term clinical outcome after thrombolysis[J]. J Neurol Sci,2012,316(1-2):99-103.
[5] LEES K R, BLUHMKI E, VON KUMMER R, et al. Time to treatment with intravenous alteplase and outcome in stroke:an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials[J]. Lancet,2010,375(9727):1695-1703.
[6] NEUMANN-HAEFELIN T, WITTSACK H J, WENSERSKI F, et al. Diffusion-and perfusion-weighted MRI. The DWI/PWI mismatch region in acute stroke[J]. Stroke,1999,30(8):1591-1597.
[7] SCHAEFER P W, PULLI B, COPEN W A, et al. Combining MRI with NIHSS thresholds to predict outcome in acute ischemic stroke:value for patient selection[J]. AJNR Am J Neuroradiol,2015,36(2):259-264.
[8] YOO A J, BARAK E R, COPEN W A, et al. Combining acute diffusion-weighted imaging and mean transmit time lesion volumes with National Institutes of Health Stroke Scale Score improves the prediction of acute stroke outcome[J]. Stroke,2010,41(8):1728-1735.
[9] 中华医学会神经病学分会脑血管病学组急性缺血性脑卒中诊治指南撰写组.中国急性缺血性脑卒中诊治指南2014[J].中华神经科杂志,2014,48(4):246-257. Cerebrovascular Disease Study Group, Chinese Medical Association Branch of Neurology. Chinese guidelines for acute ischemic stroke treatment 2014[J]. Chinese Journal of Neurology,2014,48(4):246-257. (in Chinese)
[10] JAUCH E C, SAVER J L, ADAMS H P JR, et al. Guidelines for the early management of patients with acute ischemic stroke:a guideline for healthcare professionals from the American Heart Association/American Stroke Association[J]. Stroke,2013,44(3):870-947.
[11] DEL ZOPPO G J, SAVER J L, JAUCH E C, et al. Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator:a science advisory from the American Heart Association/American Stroke Association[J]. Stroke,2009,40(8):2945-2948.
[12] VOGT G, LAAGE R, SHUAIB A, et al. Initial lesion volume is an independent predictor of clinical stroke outcome at day 90:an analysis of the Virtual International Stroke Trials Archive (VISTA) database[J]. Stroke,2012,43(5):1266-1272.
[13] PARSONS M W, CHRISTENSEN S, MCELDUFF P, et al. Pretreatment diffusion-and perfusion-MR lesion volumes have a crucial influence on clinical response to stroke thrombolysis[J]. J Cereb Blood Flow Metab,2010,30(6):1214-1225.
[14] WIJDICKS E F, SHETH K N, CARTER B S, et al. Recommendations for the management of cerebral and cerebellar infarction with swelling:a statement for healthcare professionals from the American Heart Association/American Stroke Association[J]. Stroke,2014,45(4):1222-1238.
[15] HACKE W, SCHWAB S, HORN M, et al. ‘Malignant’ middle cerebral artery territory infarction:clinical course and prognostic signs[J]. Arch Neurol,1996,53(4):309-315.
[16] MINNERUP J, WERSCHING H, RINGELSTEIN E B, et al. Prediction of malignant middle cerebral artery infarction using computed tomography-based intracranial volume reserve measurements[J]. Stroke,2011,42(12):3403-3409.
[17] MA H, PARSONS M W, CHRISTENSEN S, et al. A multicentre, randomized, double-blinded, placebo-controlled Phase Ⅲ study to investigate EXtending the time for Thrombolysis in Emergency Neurological Deficits (EXTEND)[J]. Int J Stroke,2012,7(1):74-80.
[18] THOMALLA G, FIEBACH J B, ØSTERGAARD L, et al. A multicenter, randomized, double-blind, placebo-controlled trial to test efficacy and safety of magnetic resonance imaging-based thrombolysis in wake-up stroke (WAKE-UP)[J]. Int J Stroke,2014,9(6):829-836. |
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|